FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2005157049> ?p ?o ?g. }

• W2005157049 abstract "Abstract Background Dll4/Notch and Ephrin-B2/EphB4 pathways play critical roles in tumor vessel development and maturation. This study evaluates the efficacy of the inhibition of both signaling pathways, alone and in combination, in reducing the growth of an autochthonous mouse tumor and assesses potential adverse effects. Methods We used the transgenic RIP1-Tag2 tumor model to study the effects of 1) inhibition of Dll4/Notch by either Dll4 allelic deletion or use of a soluble extracellular Dll4 (sDll4), 2) inhibition of Ephrin-B2/EphB4 signaling by a soluble extracellular EphB4 fused to albumin (sEphB4-Alb), and 3) inhibition of both pathways by sEphB4-Alb combined with either Dll4 allelic deletion or sDll4. To investigate adverse effects, we used inducible endothelial-specific Dll4 knock-out mice, treated with sEphB4-Alb, and carried out histopathological analysis. Results Dll4 allele deletion or soluble Dll4 treatment resulted in increased tumor vessel density, reduced mural cell recruitment and vessel perfusion which resulted in reduced tumor size. The soluble EphB4 instead reduced vessel density and vessel perfusion, leading to reduction of tumor size. Greater efficacy was observed when sEphB4-Alb was combined with either Dll4 allele deletion or sDll4 in regards to tumor size, vessel perfusion and mural cell recruitment. Induced endothelial specific Dll4 loss-of-function caused hepatic vascular alterations, which were prevented by concomitant sEphB4-Alb treatment. Conclusion Combination targeting of Dll4/Notch and Ephrin-B2/EphB4 has potential for clinical investigation, providing cumulative efficacy and increased safety over Dll4/Notch inhibition alone." @default.
• W2005157049 created "2016-06-24" @default.
• W2005157049 creator A5001109188 @default.
• W2005157049 creator A5017599867 @default.
• W2005157049 creator A5030582766 @default.
• W2005157049 creator A5045435869 @default.
• W2005157049 creator A5061713911 @default.
• W2005157049 creator A5068733356 @default.
• W2005157049 creator A5070664714 @default.
• W2005157049 creator A5071390319 @default.
• W2005157049 creator A5083579938 @default.
• W2005157049 creator A5085840076 @default.
• W2005157049 creator A5086741028 @default.
• W2005157049 date "2010-11-23" @default.
• W2005157049 modified "2023-10-16" @default.
• W2005157049 title "Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis" @default.
• W2005157049 cites W1971162717 @default.
• W2005157049 cites W1973096186 @default.
• W2005157049 cites W1974195547 @default.
• W2005157049 cites W1980819464 @default.
• W2005157049 cites W1987662957 @default.
• W2005157049 cites W1988615699 @default.
• W2005157049 cites W1996430165 @default.
• W2005157049 cites W1999429794 @default.
• W2005157049 cites W2001879388 @default.
• W2005157049 cites W2015809080 @default.
• W2005157049 cites W2017322644 @default.
• W2005157049 cites W2018516857 @default.
• W2005157049 cites W2019817592 @default.
• W2005157049 cites W2030370645 @default.
• W2005157049 cites W2040827891 @default.
• W2005157049 cites W2043071367 @default.
• W2005157049 cites W2043508733 @default.
• W2005157049 cites W2051319925 @default.
• W2005157049 cites W2056916102 @default.
• W2005157049 cites W2062240872 @default.
• W2005157049 cites W2063899343 @default.
• W2005157049 cites W2070636596 @default.
• W2005157049 cites W2073465941 @default.
• W2005157049 cites W2075773133 @default.
• W2005157049 cites W2076076619 @default.
• W2005157049 cites W2078554706 @default.
• W2005157049 cites W2089723533 @default.
• W2005157049 cites W2100100832 @default.
• W2005157049 cites W2105891671 @default.
• W2005157049 cites W2108212727 @default.
• W2005157049 cites W2115390024 @default.
• W2005157049 cites W2123486053 @default.
• W2005157049 cites W2128295200 @default.
• W2005157049 cites W2147435977 @default.
• W2005157049 cites W2153186684 @default.
• W2005157049 cites W2153726848 @default.
• W2005157049 cites W4247506353 @default.
• W2005157049 cites W4253705647 @default.
• W2005157049 doi "https://doi.org/10.1186/1471-2407-10-641" @default.
• W2005157049 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3001720" @default.
• W2005157049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21092311" @default.
• W2005157049 hasPublicationYear "2010" @default.
• W2005157049 type Work @default.
• W2005157049 sameAs 2005157049 @default.
• W2005157049 citedByCount "90" @default.
• W2005157049 countsByYear W20051570492012 @default.
• W2005157049 countsByYear W20051570492013 @default.
• W2005157049 countsByYear W20051570492014 @default.
• W2005157049 countsByYear W20051570492015 @default.
• W2005157049 countsByYear W20051570492016 @default.
• W2005157049 countsByYear W20051570492017 @default.
• W2005157049 countsByYear W20051570492018 @default.
• W2005157049 countsByYear W20051570492019 @default.
• W2005157049 countsByYear W20051570492020 @default.
• W2005157049 countsByYear W20051570492021 @default.
• W2005157049 countsByYear W20051570492022 @default.
• W2005157049 countsByYear W20051570492023 @default.
• W2005157049 crossrefType "journal-article" @default.
• W2005157049 hasAuthorship W2005157049A5001109188 @default.
• W2005157049 hasAuthorship W2005157049A5017599867 @default.
• W2005157049 hasAuthorship W2005157049A5030582766 @default.
• W2005157049 hasAuthorship W2005157049A5045435869 @default.
• W2005157049 hasAuthorship W2005157049A5061713911 @default.
• W2005157049 hasAuthorship W2005157049A5068733356 @default.
• W2005157049 hasAuthorship W2005157049A5070664714 @default.
• W2005157049 hasAuthorship W2005157049A5071390319 @default.
• W2005157049 hasAuthorship W2005157049A5083579938 @default.
• W2005157049 hasAuthorship W2005157049A5085840076 @default.
• W2005157049 hasAuthorship W2005157049A5086741028 @default.
• W2005157049 hasBestOaLocation W20051570491 @default.
• W2005157049 hasConcept C111758988 @default.
• W2005157049 hasConcept C123012128 @default.
• W2005157049 hasConcept C126322002 @default.
• W2005157049 hasConcept C142724271 @default.
• W2005157049 hasConcept C161879069 @default.
• W2005157049 hasConcept C170493617 @default.
• W2005157049 hasConcept C202751555 @default.
• W2005157049 hasConcept C2780394083 @default.
• W2005157049 hasConcept C502942594 @default.
• W2005157049 hasConcept C55493867 @default.
• W2005157049 hasConcept C71924100 @default.
• W2005157049 hasConcept C86803240 @default.
• W2005157049 hasConceptScore W2005157049C111758988 @default.
• W2005157049 hasConceptScore W2005157049C123012128 @default.

• next